Potent, Broad-Spectrum Inhibition of Human Immunodeficiency Virus Type 1 by the CCR5 Monoclonal Antibody PRO 140

CCR5 serves as a requisite fusion coreceptor for clinically relevant strains of human immunodeficiency virus type 1 (HIV-1) and provides a promising target for antiviral therapy. However, no study to date has examined whether monoclonal antibodies, small molecules, or other nonchemokine agents posse...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	J Virol
Päätekijät:	Trkola, Alexandra, Ketas, Thomas J., Nagashima, Kirsten A., Zhao, Lu, Cilliers, Tonie, Morris, Lynn, Moore, John P., Maddon, Paul J., Olson, William C.
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 2001
Aiheet:	Virus-Cell Interactions
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC113953/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11134270/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.75.2.579-588.2001
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!